5SG9

Crystal Structure of human phosphodiesterase 10 in complex with 2-[(E)-2-(4-methyl-6-pyrrolidin-1-ylpyrimidin-2-yl)ethenyl]quinoline

Experimental procedure

Experimental method	SINGLE WAVELENGTH
Source type	SYNCHROTRON
Source details	SLS BEAMLINE X10SA
Synchrotron site	SLS
Beamline	X10SA
Temperature [K]	100
Detector technology	PIXEL
Collection date	2010-10-05
Detector	PSI PILATUS 6M
Wavelength(s)	1.000000
Spacegroup name	H 3
Unit cell lengths	135.064, 135.064, 234.822
Unit cell angles	90.00, 90.00, 120.00

Refinement procedure

Resolution	43.580 - 2.130
R-factor	0.1777
Rwork	0.176
R-free	0.20330
Structure solution method	MOLECULAR REPLACEMENT
Starting model (for MR)	inhouse model
RMSD bond length	0.004
RMSD bond angle	1.182
Data reduction software	XDS
Data scaling software	XSCALE
Phasing software	PHASER
Refinement software	REFMAC (5.8.0258)

Data quality characteristics

	Overall	Inner shell	Outer shell
Low resolution limit [Å]	43.580	43.580	2.190
High resolution limit [Å]	2.130	9.530	2.130
Rmerge	0.151	0.085	1.304
Rmeas	0.169	0.095	1.453
Total number of observations	459408
Number of reflections	89332	998	6594
<I/σ(I)>	6.53	14.05	1.35
Completeness [%]	100.0	99.1	100
Redundancy	5.143	5.142	5.15
CC(1/2)	0.988	0.986	0.329

Crystallization Conditions

crystal ID	method	pH	temperature	details
1	VAPOR DIFFUSION, SITTING DROP	7.5	295	5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2